Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	6 Months Ended
Jan. 31, 2016
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows For the six months ended January 31, 2016 and 2015, income taxes paid by the Company were $53 and $37, respectively. For the six months ended January 31, 2016 and 2015, interest paid by the Company was $77 and $101, respectively. For the six months ended January 31, 2016 and 2015, the Company financed $76 and $57 respectively, in machinery and transportation equipment under installment loans. During the six months ended January 31, 2016 and 2015, there was a total of $1,141 and $155 in capital lease agreements.

Supplemental disclosure for statement of cash flows

6 Months Ended

Jan. 31, 2016

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

For the six months ended January 31, 2016 and 2015, income taxes paid by the Company were $53 and $37, respectively.

For the six months ended January 31, 2016 and 2015, interest paid by the Company was $77 and $101, respectively.

For the six months ended January 31, 2016 and 2015, the Company financed $76 and $57 respectively, in machinery and transportation equipment under installment loans.

During the six months ended January 31, 2016 and 2015, there was a total of $1,141 and $155 in capital lease agreements.